Ogen 1.25 Interactions
There are 244 drugs known to interact with Ogen 1.25 (estropipate), along with 17 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 27 are major, 198 are moderate, and 19 are minor.
- View all 244 medications that may interact with Ogen 1.25
- View Ogen 1.25 alcohol/food interactions (3)
- View Ogen 1.25 disease interactions (17)
Most frequently checked interactions
View interaction reports for Ogen 1.25 (estropipate) and the medicines listed below.
- acetaminophen / hydrocodone
- Actonel (risedronate)
- Adalat XL Plus (aspirin / nifedipine)
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- Align (bifidobacterium infantis)
- Allegra (fexofenadine)
- aspirin
- Azor (amlodipine / olmesartan)
- Benicar HCT (hydrochlorothiazide / olmesartan)
- Byetta (exenatide)
- Celebrex (celecoxib)
- Celexa (citalopram)
- Centrum Silver (multivitamin with minerals)
- Citracal + D (calcium / vitamin d)
- Claritin (loratadine)
- Colace (docusate)
- colchicine
- Copaxone (glatiramer)
- Coumadin (warfarin)
- Cymbalta (duloxetine)
- Cytomel (liothyronine)
- Darvocet-N 100 (acetaminophen / propoxyphene)
- Depakote (divalproex sodium)
- folic acid
- Hyzaar (hydrochlorothiazide / losartan)
- Lyrica (pregabalin)
- Norvasc (amlodipine)
- Synthroid (levothyroxine)
- Vitamin B12 (cyanocobalamin)
Ogen 1.25 alcohol/food interactions
There are 3 alcohol/food interactions with Ogen 1.25 (estropipate).
Ogen 1.25 disease interactions
There are 17 disease interactions with Ogen 1.25 (estropipate) which include:
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
More about Ogen 1.25 (estropipate)
- Ogen 1.25 consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: estrogens
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.